Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05AEE
|
||||
Former ID |
DIB003973
|
||||
Drug Name |
RG7935
|
||||
Drug Type |
Antibody
|
||||
Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 1 | [549547] | ||
Target and Pathway | |||||
Target(s) | Alpha-synuclein | Target Info | [544219], [550986] | ||
KEGG Pathway | Alzheimer's disease | ||||
Parkinson's disease | |||||
NetPath Pathway | Leptin Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
PANTHER Pathway | Parkinson disease | ||||
Pathway Interaction Database | Alpha-synuclein signaling | ||||
Reactome | Amyloid formation | ||||
References | |||||
Ref 544219 | alpha-Synuclein in Parkinson's Disease. Cold Spring Harb Perspect Med. 2012 February; 2(2): a009399. | ||||
Ref 550986 | The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5??ntranslated-Region-Directed Translation Blockers of the Parkinson's Alpha Synuclein Expression. Parkinson's Disease Volume 2012 (2012), Article ID 142372, Page(13). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.